Executive Director, Forecasting & Portfolio Analytics

Benefits

Parental leave

Not verified

Non-birth-parent leave

Not verified

Family-building benefits

• Fertility benefits: Not verified
• Adoption assistance: Not verified
• Surrogacy assistance: Not verified

Mental health support

Not verified

Relocation assistance

Not verified

Childcare support

Not verified

Learning budget

Not verified

Verification

Not verified checked Jun 13, 2026

Salary

$280K-$330K From the posting source checked Jun 20, 2026

401(k) match

Reported from DOL Form 5500 industry filing (not employer-specific)

Was this benefit information wrong? Tell us.

Market context

U.S. role benchmark (BLS OEWS)

$111,944 U.S. median for this role

Projected growth (BLS Employment Projections)

+13.7% - Much faster than average

U.S. benchmark only; posted salary is not compared across countries or currencies.

Matched to SOC 15-1252 - Data and ML aggregate by role bucket.

Source: U.S. Bureau of Labor Statistics, OEWS, May 2024 and Employment Projections, 2024-2034.

Role

Role function

Data From the posting source checked Jun 20, 2026

Seniority

Director Plus From the posting source checked Jun 20, 2026

Work mode

Remote From the posting source checked Jun 20, 2026

In-office days

0 days From the posting source checked Jun 20, 2026

Schedule

Shift type

Not verified

Weekend work

Not verified

Company

Company stage

Public-company From the posting source checked Jun 20, 2026

Equity

Offered Verified - SEC 10-K source checked Jun 20, 2026

Application

Cover letter

Not verified

Assessment

Not verified

Deadline

Not stated

Where they hire

State eligibility is not yet verified.

About this role

Executive Director, Forecasting & Portfolio Analytics Remote Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. We are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, which may be a promising option for patients with cancer. Overview The Executive Director, Forecasting and Portfolio Analytics will serve as the enterprise lead for commercial forecasting, portfolio analytics, and decision support at Iovance Biotherapeutics. As a core member of the Business Analytics & Insights Leadership team, this role is accountable for delivering high‑quality near‑term and long‑term global forecasts, scenario analyses, and enterprise insights that inform commercial strategy, investment decisions, and long‑range planning and governance discussions with Executive Leadership and the Board of Directors. This is a highly hands-on leadership role requiring deep technical expertise and direct ownership of forecasting and analytical work. The Executive Director is expected to be accountable for the design, build and stewardship of core forecasting models and decision-support analyses, ensuring rigorous assumptions, transparency, and confidence in outputs. External partners may be leveraged selectively for supplemental support, but this role retains clear internal ownership and execution responsibility for all critical forecasting and analytics deliverables. This position supports the ongoing commercialization of AMTAGVI® and

Read the full description at job-boards.greenhouse.io. FewerJobs shows a preview and links to the original posting.